Riskpilot← Back to searchSign inGet full accessFlyinge Consultant Physicians AB
ABActiveOrg 5569895229Flyingeby 851Medical specialists activities · NACE 8622Est. 20140 employees
Revenue 2024
SEK 1,9M
-30% vs 2023
EBITDA margin
31.9%
-57% vs 2023
Equity ratio
90.0%
Financial strength
Net profit 2024
SEK 383K
-68% vs 2023
| Revenue | SEK 1,9M | -30% |
| EBITDA | SEK 604K | -57% |
| Net profit | SEK 383K | -68% |
| Total assets | SEK 9,5M | -6% |
| Equity | SEK 8,5M | -1% |
| Employees | 0 | — |
Legal name
Flyinge Consultant Physicians AB
Org number
5569895229
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
6 november 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för företagets verksamhet är att -erbjuda specialistläkarkompetens för uppdrag inom akutsjukvård, prehospitalsjukvård och internmedicin i Sverige och utomlands. -erbjuda resemedicinsk- och expeditionsmedicinsk expertis. -utveckla koncept för medicinsk försörjning, ge förslag till medicinsk utrustning och göra specialistläkare tillgängliga för uppdrag på orter där det finns brister i det lokala hälso- och sjukvårdssystemet. -erbjuda specialistläkarkompetens inom telefonrådgivning (Regionalt Läkarstöd) för ambulansverksamhet.
Address
Flyingeby 851
Email
flyinge.consultant.physicians@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 777 | 3 106 | 2 998 | 2 844 | 2 941 | 2 800 | 2 721 | 1 897 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −1 262 |
| EBITDA | 1 036 | 1 378 | 2 101 | 2 167 | 1 999 | 1 758 | 1 620 | 1 500 | 1 418 | 604 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| EBIT | 1 036 | 1 378 | 2 101 | 2 167 | 1 999 | 1 758 | 1 620 | 1 500 | 1 418 | 604 |
| Net financials | — | — | −1 | −1 | −1 | −1 | — | — | 84 | 40 |
| Profit before tax | 1 036 | 1 033 | 1 575 | 2 166 | 1 999 | 1 756 | 1 620 | 1 844 | 1 521 | 484 |
| Tax | −228 | −227 | −347 | −478 | −429 | −377 | −335 | −385 | −321 | −101 |
| Net profit | 808 | 806 | 1 228 | 1 688 | 1 570 | 1 379 | 1 285 | 1 459 | 1 200 | 383 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 018 | 2 738 | 3 443 | 5 178 | 6 337 | 7 288 | 8 208 | 8 784 | 10 056 | 9 451 |
| Equity | 858 | 1 507 | 2 338 | 3 796 | 5 024 | 6 047 | 6 923 | 7 897 | 8 613 | 8 510 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 160 | 887 | 236 | 514 | 445 | 372 | 416 | 362 | 938 | 276 |
| Total debt | 160 | 887 | 236 | 514 | 445 | 372 | 416 | 362 | 938 | 276 |
EBITDA margin
31.9%
This company
15.8%
Market median
+102% vs market
20152024
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20152024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20152024
Net profit margin
20.2%
This company
8.1%
Market median
+149% vs market
20152024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20152024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-11-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SI Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Flyinge Consultant Physicians AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Simone Ingrid Bratfisch | Chief Executive Officer | 0 companies |
| Kolja Gilli | Deputy Board Member | 0 companies |